Safety and Efficacy Study to Compare Capecitabine + Bevacizumab Versus Capecitabine, Concomitantly With Radiotherapy as Neoadjuvant Treatment for Patients With Localized and Resectable Rectal Cancer

Update Il y a 4 ans
Reference: NCT01043484

Woman and Man

  • | Country :
  • Spain
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The purpose of the study is to evaluate the efficacy and safety of the combination of capecitabine + bevacizumab concomitantly with radiotherapy versus capecitabine concomitantly with radiotherapy, as neoadjuvant treatment for patients with localized and resectable rectal cancer.


Inclusion criteria

  • Rectal cancer

Links